ProfileGDS4718 / 1555516_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 19% 13% 48% 12% 15% 15% 10% 11% 17% 22% 16% 24% 13% 10% 8% 16% 26% 13% 24% 14% 17% 18% 17% 18% 16% 14% 23% 8% 19% 12% 11% 17% 16% 20% 17% 8% 16% 19% 14% 34% 16% 15% 9% 10% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.1377919
GSM549102patient 115, normal, homogenized [OPG study]3.8896513
GSM549104patient 119, normal, homogenized [OPG study]5.3981248
GSM549108patient 138, normal, homogenized [OPG study]3.883612
GSM549119patient 077, normal, homogenized [OPG study]3.9769615
GSM549133patient 032, cancer, homogenized [OPG study]3.9043115
GSM549139patient 042, cancer, homogenized [OPG study]3.7545210
GSM549099patient 107, normal, homogenized [OPG study]3.833611
GSM549109patient 139, normal, homogenized [OPG study]4.0555617
GSM549110patient 046, normal, homogenized [OPG study]4.2051222
GSM549114patient 063, normal, homogenized [OPG study]3.9712816
GSM549122patient 082, normal, homogenized [OPG study]4.2908724
GSM549134patient 033, cancer, homogenized [OPG study]3.8871913
GSM549136patient 036, cancer, homogenized [OPG study]3.7559410
GSM549140patient 044, cancer, homogenized [OPG study]3.686998
GSM549111patient 047, normal, homogenized [OPG study]3.9780416
GSM549113patient 057, normal, homogenized [OPG study]4.329126
GSM549132patient 031, cancer, homogenized [OPG study]3.875713
GSM549137patient 038, cancer, homogenized [OPG study]4.2978524
GSM549142patient 047, cancer, homogenized [OPG study]4.0081414
GSM549100patient 110, normal, homogenized [OPG study]4.0380817
GSM549107patient 135, normal, homogenized [OPG study]4.0322918
GSM549115patient 068, normal, homogenized [OPG study]3.9942817
GSM549116patient 072, normal, homogenized [OPG study]4.0429218
GSM549120patient 078, normal, homogenized [OPG study]3.9895416
GSM549131patient 030, cancer, homogenized [OPG study]3.8964814
GSM549118patient 074, normal, homogenized [OPG study]4.257523
GSM549129patient 027, cancer, homogenized [OPG study]3.70428
GSM549123patient 088, normal, homogenized [OPG study]4.1113219
GSM549124patient 006, cancer, homogenized [OPG study]3.8864312
GSM549126patient 015, cancer, homogenized [OPG study]3.7868211
GSM549128patient 025, cancer, homogenized [OPG study]4.0093717
GSM549103patient 117, normal, homogenized [OPG study]4.030916
GSM549117patient 073, normal, homogenized [OPG study]4.12820
GSM549138patient 041, cancer, homogenized [OPG study]3.9981717
GSM549141patient 045, cancer, homogenized [OPG study]3.669258
GSM549130patient 028, cancer, homogenized [OPG study]4.0036116
GSM549101patient 111, normal, homogenized [OPG study]4.0964819
GSM549105patient 128, normal, homogenized [OPG study]3.9365414
GSM549106patient 134, normal, homogenized [OPG study]4.6672534
GSM549112patient 048, normal, homogenized [OPG study]3.9986816
GSM549125patient 011, cancer, homogenized [OPG study]3.9817115
GSM549127patient 024, cancer, homogenized [OPG study]3.736619
GSM549135patient 035, cancer, homogenized [OPG study]3.7438410